THE COST-EFFECTIVENESS OF STRATEGIES TO VACCINATE AGAINST VARICELLA IN MEXICO

OBJECTIVES: The annual reported incidence of varicella in Mexico between 2010-2014 ranged from 221,000-371,000 cases annually. Seroprevalence data indicates that the true number of cases is likely between 1.6-2.3 M annually. Despite availability of varicella vaccines in the private sector and for se...

Full description

Saved in:
Bibliographic Details
Published in:Value in health 2017-05, Vol.20 (5), p.A77
Main Authors: Perezbolde, C, Monsanto, H, Pillsbury, M, Kyle, J, Wolfson, LJ
Format: Article
Language:English
Subjects:
Age differences
Campaigns
Chicken pox
Cost analysis
Experts
Health care expenditures
Help seeking behavior
Immunization
Infections
Patients
Private sector
Public sector
Resource utilization
Serology
Uptake
Vaccines
Varicella
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:OBJECTIVES: The annual reported incidence of varicella in Mexico between 2010-2014 ranged from 221,000-371,000 cases annually. Seroprevalence data indicates that the true number of cases is likely between 1.6-2.3 M annually. Despite availability of varicella vaccines in the private sector and for selected patients in the public sector since 2000, vaccine uptake remains variable. The objective of this study was to evaluate the cost-effectiveness of possible varicella vaccination strategies in Mexico. METHODS: A dynamic transmission model of varicella infection was calibrated to reported age-specific outpatient varicella incidence data from 2003-2011, and adjusted for care-seeking behaviour patterns. Ten experts from Mexican health institutions provided input to summarize patterns of health care resource utilization (HCRU) for natural varicella among patients in different age groups (
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2017.05.005